BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s stock price dropped 2.6% on Thursday . The company traded as low as $0.1951 and last traded at $0.2083. Approximately 2,649,365 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 62,169,492 shares. The stock had previously closed at $0.2138.
BioRestorative Therapies Stock Performance
The business’s fifty day moving average price is $0.84 and its 200-day moving average price is $1.22. The stock has a market cap of $341.53 million, a PE ratio of -0.19 and a beta of 102.36.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc is a clinical‐stage regenerative medicine company focused on developing and commercializing advanced therapeutic platforms to promote tissue repair and healing. The company’s principal business activities are conducted through its wholly owned subsidiary, TissueForm, Inc, which holds the rights to a proprietary micro‐fiber scaffold technology designed to create a three‐dimensional matrix supporting cell migration, proliferation and new tissue formation. BioRestorative’s work is primarily targeted at chronic and non‐healing wounds, including diabetic foot ulcers and other complex soft‐tissue injuries.
The cornerstone of BioRestorative’s product pipeline is the TissueForm® line of scaffold materials.
See Also
- Five stocks we like better than BioRestorative Therapies
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
